Insulet has announced the FDA clearance of Omnipod GO, an insulin delivery device cleared for use for people with tTpe 2 diabetes age 18 or
Diabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, are being studied to tackle some of the most difficult-to-treat brain disorders, including
A new report into the state of diabetes care in England has revealed thousands of excess deaths, ‘deeply alarming’ numbers of missed checks and stark
Because Great Britain never adopted the European Union’s Medical Devices Regulation (MDR) because its delayed date of application happened after the end of the Brexit
While mobile app developers have created a range of software tools to help people with diabetes manage their conditions, evidence to support mobile health apps
New research presented at the Diabetes UK Professional Conference 2023 has revealed that a molecule secreted by frogs could offer a new treatment option for
The Internet of Medical Things (IoMT) has enabled medical devices to transmit data and physicians to remotely adjust settings to tailor treatments. However, connecting medical
Patients taking metformin for Type 2 diabetes had a lower risk of developing osteoarthritis than did patients taking a sulfonylurea, according to a study published
The European Commission (EC) has given authorization for ruxolitinib (Opzelura) cream 15 mg/g to be marketed for treating nonsegmental vitiligo, a chronic autoimmune disease characterized by
The FDA has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for individuals 6 years of age and older with
